Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 61
- +2 vs. Q1 2024
- Portfolio value
- $1.90B
- −$125.8M (−6.2%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 4,279,464 | $166.1M | 8.7% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $128.9M | 6.8% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $113.8M | 6.0% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $112.4M | 5.9% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $103.1M | 5.4% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 650,000 | $102.7M | 5.4% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,120,192 | $85.0M | 4.5% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $77.3M | 4.1% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $71.3M | 3.8% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,727,388 | $70.6M | 3.7% | 00.0% | Unchanged | – |
| TNGXTango Therapeutics, Inc. | COM | 8,198,642 | $70.3M | 3.7% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,726,000 | $66.2M | 3.5% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,946,915 | $43.7M | 2.3% | +1,142,857+63.3% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 100,000 | $43.0M | 2.3% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 1,676,733 | $39.3M | 2.1% | 00.0% | Unchanged | History |
| NKTXNkarta, Inc. | COM | 5,607,350 | $33.1M | 1.7% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $32.6M | 1.7% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $32.2M | 1.7% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $31.6M | 1.7% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 8,215,910 | $26.9M | 1.4% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 600,000 | $26.6M | 1.4% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 2,000,000 | $26.0M | 1.4% | 00.0% | Unchanged | History |
| GERNGeron Corp | COM | 6,000,000 | $25.4M | 1.3% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,602,200 | $24.4M | 1.3% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $23.4M | 1.2% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 825,000 | $21.8M | 1.1% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,000,000 | $20.6M | 1.1% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,590,000 | $18.7M | 1.0% | 00.0% | Unchanged | History |
| CLYMClimb Bio, Inc. | COM | 2,603,190 | $18.5M | 1.0% | +2,603,190 | New | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $16.4M | 0.9% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 696,480 | $16.4M | 0.9% | +446,480+178.6% | Added | History |
| ARVNArvinas, Inc. | COM | 608,614 | $16.2M | 0.9% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 400,000 | $15.7M | 0.8% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 671,358 | $15.7M | 0.8% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 690,000 | $14.2M | 0.7% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 1,536,341 | $13.8M | 0.7% | +1,536,341 | New | History |
| PSTXPoseida Therapeutics, Inc. | COM | 4,475,000 | $13.1M | 0.7% | 00.0% | Unchanged | History |
| IPSCCentury Therapeutics, Inc. | COM | 4,901,603 | $12.5M | 0.7% | +3,151,603+180.1% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,732,571 | $12.2M | 0.6% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,819,132 | $11.9M | 0.6% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 657,895 | $11.5M | 0.6% | +657,895 | New | History |
| PRLDPrelude Therapeutics Inc | COM | 2,568,287 | $9.79M | 0.5% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 3,850,000 | $8.97M | 0.5% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 1,545,000 | $8.44M | 0.4% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 350,000 | $7.95M | 0.4% | 00.0% | Unchanged | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 650,000 | $7.03M | 0.4% | +650,000 | New | History |
| ENGNenGene Therapeutics Inc. | COM | 727,900 | $6.86M | 0.4% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 750,000 | $6.01M | 0.3% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 1,500,000 | $2.85M | 0.2% | 00.0% | Unchanged | History |
| BOLDBoundless Bio, Inc. | COM | 711,329 | $2.75M | 0.1% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 506,000 | $2.36M | 0.1% | 00.0% | Unchanged | History |
| ABSIAbsci Corp | COM | 700,000 | $2.16M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 238,193 | $1.94M | 0.1% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 450,000 | $1.84M | 0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 811,627 | $1.69M | 0.1% | +602,400+287.9% | Added | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 166,000 | $1.41M | 0.1% | 00.0% | UnchangedConverted for a 1-for-25 split | History |
| BCABBioAtla, Inc. | COM | 686,347 | $940.3K | <0.1% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 309,007 | $407.9K | <0.1% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 250,000 | $200.3K | <0.1% | −250,000−50.0% | Reduced | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $42.7K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $1.11K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q1 2024 (2)
Positions held at the end of Q1 2024 that are gone from this filing.